Physician profile
Michael U Yu
NPI 1891782835
$4,450.16
in general payments reported to CMS, 2019-2025
42 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $260 · 2021: $627 · 2022: $510 · 2023: $869 · 2024: $799 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $652.11 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $601.98 | 2020-2025 | Evenity, Prolia, Repatha |
| Lilly USA, LLC | $570.67 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $329.86 | 2021-2025 | |
| Antares Pharma, INC. | $207.43 | 2020-2025 | Xyosted |
| Exact Sciences Corporation | $203.60 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $194.16 | 2021-2025 | |
| Glaxosmithkline, LLC. | $180.22 | 2020-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.68 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $143.49 | 2019-2023 | |
| Amarin Pharma, INC. | $103.04 | 2020-2021 | |
| Esperion Therapeutics, INC. | $84.63 | 2024-2025 | Nexletol |
| Myriad Women'S Health, INC. | $82.34 | 2023 | Myrisk |
| Astrazeneca Pharmaceuticals Lp | $79.77 | 2019-2025 | Farxiga |
| Biohaven Pharmaceuticals, INC. | $72.18 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.